Telix Pharmaceuticals Ltd (TLX.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in thousands)
| 12-2025 | 12-2024 | 12-2023 | 12-2022 | 12-2021 | |
| Cash Flows From Operating Activities | |||||
| Operating Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -25,692 | -8,906 | -6,594 | -4,788 | -971 |
| Net Acquisitions | -229,029 | -21,574 | N/A | -662 | N/A |
| Purchase Of Investment | -892 | -32,328 | -8,963 | N/A | N/A |
| Purchase Sale Intangibles | -18,084 | -12,256 | -760 | -4,642 | N/A |
| Other Investing Activity | -12,224 | -8,991 | -1,049 | -1,471 | -1,005 |
| Investing Cash Flow | $-285,921 | $-84,054 | $-17,366 | $-11,563 | $-1,976 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 529 | 407,881 | 3,922 | 2,050 | N/A |
| Debt Repayment | -6,056 | -1,946 | N/A | -9 | -246 |
| Common Stock Issued | 1,808 | 621 | 4,532 | 123,161 | 2,742 |
| Other Financing Activity | 0 | -9,255 | -1,514 | -6,177 | -432 |
| Financing Cash Flow | $-3,719 | $397,301 | $6,940 | $119,025 | $2,063 |
| Exchange Rate Effect | 8,800 | 25,078 | -1,140 | 203 | 2,392 |
| Beginning Cash Position | 439,999 | 76,632 | 79,255 | 14,992 | 56,503 |
| End Cash Position | 141,866 | 441,714 | 83,961 | 79,139 | 15,975 |
| Net Cash Flow | $-306,933 | $340,003 | $5,846 | $63,943 | $-42,921 |
| Free Cash Flow | |||||
| Capital Expenditure | -43,776 | -21,162 | -7,354 | -9,430 | -971 |
| Free Cash Flow | -43,776 | -21,162 | -7,354 | -9,430 | -971 |